Having confirmed that BiP is upregulated in zebrafish models of DMD, we wished to determine if the atrogin1-BiP axis we have identified contributes to DMD pathology and could be manipulated for potential therapeutic gain. The gene discussed is HSPA5; the disease is Duchenne muscular dystrophy.